Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.06 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including other brain neurons; strongest in papillary tip epithelial cells | 0.75 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 39 Parkinson's papers of 8,153 | 0.52 |
| pathways Reactome | 30 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 4694
Sealed predictions
- CDC42 in dopamine neurons, braak+0.09 (p 0.815) → +0.39 (p 0.299)receipt 4702
Swarm cases
receipt 4702: CDC42 in dopamine neurons, braak
- power
- full sample +0.22 (p 0.384, n 18), 95% CI -0.28 to +0.62. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.23 (p 0.365, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.22 (p 0.374, n 18). could be the mix.
- skeptic
- leave-one-out range +0.12 to +0.30, sign flips 0; without severely affected donors +0.22 (p 0.384, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CDC42 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts